Anti-migration and anti-angiogenic effects of tanshinone IIA on breast cancer cell MDA-MB-435

Journal of China Pharmaceutical University

Volumn 40, Issue 6, 2009, Pages 565-570

  Xu, Chang Liang ^a   Xi, Tao ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Gene expression; Migration; Tanshinone IIA

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIMITOTIC AGENT; MESSENGER RNA; MYC PROTEIN; TANSHINONE IIA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HIF 1ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; ARTICLE; ASSAY; BREAST CANCER; CANCER CELL CULTURE; CATTLE; CELL FUNCTION; CELL PROLIFERATION; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; ENDOTHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; MIGRATION INHIBITION; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WOUND HEALING;

EID: 75649096054     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Nieva J. Ladanyi A, Bethel K, et al. Fast and sensitive detection of occult tumor cells in peripheral blood [E]. AACR Meeting Abstracts,2005: 1 312.
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease[J]. Nat Med, 1995,1(1): 27-31.
3. Smith NR, James NH, Oakley I, et al. Acute pharmacodynamic and antivascular effects of the vascular endothelial growth factor signaling inhibitor AZD2171 in Calu-6 human lung tumor xenografts[J]. Mol Cancer Ther, 2007,6(8): 198-208.
4. Duda DG, Batchelor TT, Willett CG, et al. VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects [J]. Trends Mol Med, 2007,13(6): 223-230.
5. Podsypanina K, Du YC, Jechlinger M, et al. Seeding and propagation of untransformed mouse mammary cells in the lung [J]. Science, 2008,321(5 897): 1 841-1 844.
6. Bert E, Bartsch H, Gerhäuser C. Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention [J]. Mol Cancer Ther, 2006,5(3): 575-585.
7. Li QF, Shi SL, Liu QR, et al. Anticancer effects of ginsenoside Rg1, cinnamic acid, and tanshinone IIA in osteosarcoma MG-63 cells: Nuclear matrix downregulation and cytoplasmic trafficking of nucleophosmin [J]. Int J Biochem Cell Biol, 2008,40 (1): 1 918-1 929.
8. Lee WY, Chiu LC, Yeung JH. Cytotoxicity of major tanshinones isolated from Danshen (Salvia miltiorrhiza ) on HepG2 cells in relation to glutathione perturbation [J]. Food Chem Toxicol, 2008,46(1): 328-338.
9. Su CC, Chen GW, Kang JC, et al. Growth inhibition and apoptosis induction by tanshinone IIA in human colon adenocarcinoma cells[J]. Planta Med ,2008,74(11): 1 357-1 362.
10. Wang J, Wang XJ, Jiang S, et al. Growth inhibition and induction of apoptosis and differentiation of tanshinone IIA in human glioma cells[J]. J Neurooncol,2007,82(1): 11-21.
11. Kim HP,Lee JY,Jeong JK,et al. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor a localized in caveolae[J]. Biochem Biophys Res Commun, 1999, 263(1): 257-262.
12. Balch C, Yan P, Craft T, et al. Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cance [J]. Mol Cancer Ther,2005,4(10): 1 505-1 514.
13. Yi TF, Yi ZF, Cho SG,et al. Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling [J]. Cancer Res, 2008,68 (6): 1 843-1 850.
14. Kern J, Bauer M, Rychli K, et al. Alternative splicing of vasohibin-1 generates an inhibitor of endothelial cell proliferation, migration , and capillary Tube Formation [J]. Arterioscler Thromb Vasc Biol, 2008,28(3): 478-484.
15. Gardner L, Lee L, Dang C. The c-Myc oncogenic transcription factor[EB/OL]. [2009-09-18]http://www.myc-cancer-gene. org/documents/MycReview. pdf.
16. Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism[J]. Mol Cell Biol,1999,19(1): 1-11.
17. Baudino TA, McKay C, Pendeville-Samain H, et al. c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression [J]. Genes Dev, 2002,16 (19): 2 530-2 543.
18. Knies-Bamforth UE, Fox SB, Poulsom R, et al. c-Myc interacts with hypoxia to induce angiogenesis in vivo by a vascular endothelial growth factor-dependent mechanism [J]. Cancer Res, 2004, 64(6): 6 563 -6 570.
19. Brüne B, Zhou J. Nitric oxide and superoxide: Interference with hypoxic signaling[J]. Cardiovasc Res,2007,75(2): 275-282.
20. Oh JM, Ryoo IJ, Yang Y, et al. Hypoxia-inducible transcription factor (HIF)-1α stabilization by actin-sequestering protein, thymosin beta-4 (TB4) in HeLa cervical tumor cells [J]. Cancer Lett,2008, 264(1): 29-35.
21. Hockel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects[J]. J Natl Cancer Inst, 2001,93(4): 266-276.
22. Chan DA, Krieg AJ,Turcotte S, et al. HIF gene expression in cancer therapy [J]. Methods Enzymol, 2007, 435 (3): 323 -345.
23. Elstner A, Holtkamp N, Deimling A. Involvement of HIF-1 in desferrioxamine-induced invasion of glioblastoma cells[J]. Clin Exp Metastasis,2007,24(1): 57-66.
24. Michaelis M, Michaelis UR, Fleming I, et al. Valproic acid inhibits angiogenesis in vitro and in vivo [J]. Mol Pharmacol, 2004, 65(3): 520-527.